Re: Neratinib Clinical Trial
I have wanted to join this trial since last summer when my oncologist first told me it would be available after I finished with my TCH regimen this July. But I won't get the chance. I unfortunately learned yesterday from his trials nurse that my gender makes me ineligible. I will have to find some other way to get exposure to a tyrosine kinase inhibitor like Neratinib. Perhaps there is a CAM regimen that would help.
Despite this set back, I am grateful to all the ladies who have signed up for the trial and by their efforts will advance the knowledge base for treating Her2 BC.
bird
__________________
Male Breast Cancer, DX 5/15/09, IDC, STAGE 1, 1.7 cm, HER2+++, ER+(95%)/PR+(75%), Ki67 40%, grade 3, 0/5 nodes, TX: mastectomy, TCH finished 7/19/10, radiation 6 wks., Tamoxifen on going, bisphosphonate 24 mos.
|
Hybrid Mode
